Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obama catapults patient-empowered Precision Medicine.

Nature biotechnology·2015
Same author

Agricultural probiotics enter spotlight.

Nature biotechnology·2015
Same author

Technology comes to typing.

Nature biotechnology·2014
Same author

Second MRSA antibiotic reaches the market.

Nature biotechnology·2014
Same author

FDA launches two research centers with academia.

Nature biotechnology·2014
Same author

First vanguard anti-MRSA agent approved.

Nature biotechnology·2014

Related Experiment Video

Updated: Jul 18, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

The business of developing antibacterials.

Jeffrey L Fox

    Nature Biotechnology
    |December 13, 2006
    PubMed
    Summary

    Despite technical challenges, numerous companies are developing new products for a vital, albeit slow-growing, medical market. Innovation continues in this important therapeutic area.

    Area of Science:

    • Pharmaceutical Development
    • Medical Devices
    • Biotechnology

    Background:

    • The market for new medical products is crucial for patient care.
    • Despite some setbacks, research and development continue.
    • This sector experiences modest but steady growth.

    Purpose of the Study:

    • To explore the landscape of new product development in a key medical market.
    • To identify ongoing efforts by pharmaceutical and biotechnology companies.
    • To understand the challenges and opportunities in this sector.

    Main Methods:

    • Review of current industry trends and R&D pipelines.
    • Analysis of market dynamics and investment in the sector.
    • Case studies of companies pursuing product innovation.

    More Related Videos

    Assay Development for High-Throughput Drug Screening Against Mycobacteria
    07:50

    Assay Development for High-Throughput Drug Screening Against Mycobacteria

    Published on: October 25, 2024

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
    11:15

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

    Published on: July 24, 2021

    Related Experiment Videos

    Last Updated: Jul 18, 2026

    Antibiotic Dereplication Using the Antibiotic Resistance Platform
    10:49

    Antibiotic Dereplication Using the Antibiotic Resistance Platform

    Published on: October 17, 2019

    Assay Development for High-Throughput Drug Screening Against Mycobacteria
    07:50

    Assay Development for High-Throughput Drug Screening Against Mycobacteria

    Published on: October 25, 2024

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
    11:15

    Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

    Published on: July 24, 2021

    Main Results:

    • Several companies, both small and large, are actively seeking new products.
    • Past technical approaches have not always yielded success.
    • The market remains medically important despite its modest growth rate.

    Conclusions:

    • Continued investment and innovation are occurring in this critical medical market.
    • The pursuit of novel solutions persists despite development hurdles.
    • The market's importance justifies ongoing research and commercial interest.